Brown Wealth Management’s AbbVie ABBV Stock Holding History

Brown Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$433K	Buy	1,722 +77	+5%	+$16.6K	0.1%	88
2026 Q1	$358K	Sell	1,645 -69	-4%	-$15.3K	0.09%	88
2025 Q4	$392K	Buy	1,714 +203	+13%	+$46.2K	0.1%	77
2025 Q3	$350K	Buy	1,511 +181	+14%	+$36.9K	0.1%	78
2025 Q2	$247K	Buy	1,330 +72	+6%	+$13.4K	0.08%	89
2025 Q1	$264K	Buy	+1,258	New	+$245K	0.09%	79
2024 Q4	–	Sell	-4,464	Closed	-$882K	–	86
2024 Q3	$882K	Buy	4,464 +61	+1%	+$11.4K	0.32%	43
2024 Q2	$755K	Buy	4,403 +1	+0%	+$166	0.3%	46
2024 Q1	$802K	Sell	4,402 -87	-2%	-$15K	0.33%	44
2023 Q4	$696K	Hold	4,489	–	–	0.31%	45
2023 Q3	$669K	Sell	4,489 -253	-5%	-$37.1K	0.32%	43
2023 Q2	$639K	Buy	+4,742	New	+$695K	0.33%	47

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Brown Wealth Management's ABBV Position: Q2 2026 in Review

Brown Wealth Management increased its AbbVie (ABBV) stake by 4.7% in Q2 2026, buying an estimated $16.6K and bringing the position to 1,722 shares worth $433K. The position accounts for 0.1% of the portfolio, ranked #88.

Brown Wealth Management first reported a position in ABBV in Q2 2023 and has held it in 12 quarters since. The position peaked at $882K in Q3 2024. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Brown Wealth Management held 1,722 shares of AbbVie worth $433K as of Q2 2026.
Brown Wealth Management bought 77 AbbVie shares in Q2 2026, an estimated $16.6K.
AbbVie made up 0.1% of Brown Wealth Management's portfolio in Q2 2026, its #88 holding.
Brown Wealth Management first reported a position in AbbVie in Q2 2023 and has held it in 12 quarters since.
Brown Wealth Management's AbbVie position peaked at $882K in Q3 2024.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Brown Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.